Login / Signup

Structure and inhibition of N-acetylneuraminate lyase from methicillin-resistant Staphylococcus aureus.

Rachel A NorthAndrew J A WatsonF Grant PearceAndrew C Muscroft-TaylorRosmarie FriemannAntony J FairbanksRenwick C J Dobson
Published in: FEBS letters (2016)
N-Acetylneuraminate lyase is the first committed enzyme in the degradation of sialic acid by bacterial pathogens. In this study, we analyzed the kinetic parameters of N-acetylneuraminate lyase from methicillin-resistant Staphylococcus aureus (MRSA). We determined that the enzyme has a relatively high KM of 3.2 mm, suggesting that flux through the catabolic pathway is likely to be controlled by this enzyme. Our data indicate that sialic acid alditol, a known inhibitor of N-acetylneuraminate lyase enzymes, is a stronger inhibitor of MRSA N-acetylneuraminate lyase than of Clostridium perfringens N-acetylneuraminate lyase. Our analysis of the crystal structure of ligand-free and 2R-sialic acid alditol-bound MRSA N-acetylneuraminate lyase suggests that subtle dynamic differences in solution and/or altered binding interactions within the active site may account for species-specific inhibition.
Keyphrases
  • methicillin resistant staphylococcus aureus
  • staphylococcus aureus
  • electronic health record
  • transcription factor
  • machine learning
  • big data
  • multidrug resistant
  • cell surface
  • artificial intelligence